Showing results (131-140 of 161) with videos related to
Sort By:
Pageof 17
AIDS Research and Human Retroviruses|September 1, 1990
HIV-1 neutralizing monoclonal antibodies induced by a synthetic peptideP J Durda, L Bacheler, P Clapham, et al.AIDS (London, England)|December 1, 1989
Oligosaccharide-mediated interactions of the envelope glycoprotein gp120 of HIV-1 that are independent of CD4 recognitionM Larkin, R A Childs, T J Matthews, et al.AIDS Research and Human Retroviruses|March 1, 1995
A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDAG Pialoux, J L Excler, Y Rivière, et al.AIDS Research and Human Retroviruses|December 1, 1995
Safety and immunogenicity of a recombinant HIV type 1 glycoprotein 160 boosted by a V3 synthetic peptide in HIV-negative volunteersD Salmon-Céron, J L Excler, D Sicard, et al.Virology|April 11, 1992
V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivityL A Ivanoff, J W Dubay, J F Morris, et al.Radiation Protection Dosimetry|September 6, 2011
Review of bubble detector response characteristics and results from spaceB J Lewis, M B Smith, H Ing, et al.Journal of Virology|July 1, 1992
Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1P W Berman, T J Matthews, L Riddle, et al.AIDS Research and Human Retroviruses|July 1, 1993
A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibodyJ D Laman, M M Schellekens, G K Lewis, et al.Lancet (London, England)|April 23, 1988
Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individualsK J Weinhold, H K Lyerly, T J Matthews, et al.The Journal of Experimental Medicine|March 1, 1993
Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope proteinB F Haynes, L O Arthur, P Frost, et al.Pageof 17